Harmony Biosciences Inc. (HRMY)

29.68

0.07 (0.24%)

At close: Apr 28, 2025, 10:49 AM

Harmony Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	145.49M	128.85M	181.47M	34.6M	-36.94M	-151.98M	-39.9M
Depreciation & Amortization	24.11M	24.36M	23.39M	18.84M	10.24M	3.21M	184K
Stock-Based Compensation	42.6M	31.7M	26.17M	15.66M	4.69M	9.91M	1.08M
Other Working Capital	n/a	46.55M	12.87M	15.46M	12.83M	8.74M	446K
Other Non-Cash Items	36.91M	12.85M	3.49M	2.68M	4.91M	55.13M	2.06M
Deferred Income Tax	-29.3M	-13.42M	-85.94M	26.15M	25.75M	n/a	n/a
Change in Working Capital	n/a	35.03M	-4.11M	631K	-11.63M	8.29M	-164K
Operating Cash Flow	219.82M	219.39M	144.47M	98.56M	-2.98M	-75.44M	-38.8M
Capital Expenditures	-1.15M	-312K	-40.17M	-100.3M	-2M	-127.15M	-1.34M
Cash Acquisitions	-33.07M	-36.97M	141.83M	-100M	-2M	-52M	n/a
Purchase of Investments	-105.29M	-127.47M	-110.73M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	98.53M	118.31M	9.07M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-26.5M	n/a	-141.83M	100M	2M	52M	n/a
Investing Cash Flow	-67.48M	-46.44M	-141.83M	-100.3M	-2M	-127.15M	-1.34M
Debt Repayment	-15M	-1.25M	-2M	-500K	79.42M	100M	n/a
Common Stock Repurchased	n/a	-100M	n/a	n/a	-167K	-1.13M	-3.2M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4M	-3.79M	8.84M	-22.08M	129.93M	43.77M	-185K
Financial Cash Flow	-11M	-105.55M	6.84M	7.42M	209.16M	143.77M	21.61M
Net Cash Flow	141.34M	67.4M	9.47M	5.68M	204.17M	-58.82M	-18.53M
Free Cash Flow	218.67M	219.07M	104.29M	-1.74M	-4.99M	-202.59M	-40.14M